Newbridge Financial Services Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.4K | Buy |
256
+1
| +0.4% | +$111 | ﹤0.01% | 632 |
|
|
2025
Q1 | $28.5K | Sell |
255
-103
| -29% | -$11.5K | 0.01% | 483 |
|
|
2024
Q4 | $33.1K | Buy |
+358
| New | +$33.1K | 0.01% | 504 |
|
|
2024
Q3 | – | Sell |
-4,165
| Closed | -$286K | – | 822 |
|
|
2024
Q2 | $286K | Buy |
4,165
+2,462
| +145% | +$169K | 0.11% | 137 |
|
|
2024
Q1 | $125K | Sell |
1,703
-925
| -35% | -$67.8K | 0.05% | 258 |
|
|
2023
Q4 | $213K | Sell |
2,628
-626
| -19% | -$50.7K | 0.1% | 181 |
|
|
2023
Q3 | $244K | Buy |
3,254
+1,131
| +53% | +$84.8K | 0.12% | 167 |
|
|
2023
Q2 | $164K | Buy |
2,123
+336
| +19% | +$25.9K | 0.08% | 229 |
|
|
2023
Q1 | $148K | Sell |
1,787
-147
| -8% | -$12.2K | 0.08% | 245 |
|
|
2022
Q4 | $166K | Sell |
1,934
-1,563
| -45% | -$134K | 0.1% | 210 |
|
|
2022
Q3 | $216K | Sell |
3,497
-92
| -3% | -$5.68K | 0.13% | 178 |
|
|
2022
Q2 | $222K | Buy |
3,589
+529
| +17% | +$32.7K | 0.14% | 150 |
|
|
2022
Q1 | $182K | Buy |
3,060
+255
| +9% | +$15.2K | 0.09% | 214 |
|
|
2021
Q4 | $204K | Buy |
2,805
+104
| +4% | +$7.56K | 0.1% | 200 |
|
|
2021
Q3 | $189K | Buy |
2,701
+3
| +0.1% | +$210 | 0.12% | 178 |
|
|
2021
Q2 | $186K | Sell |
2,698
-34
| -1% | -$2.34K | 0.11% | 184 |
|
|
2021
Q1 | $177K | Buy |
2,732
+250
| +10% | +$16.2K | 0.13% | 177 |
|
|
2020
Q4 | $145K | Sell |
2,482
-25
| -1% | -$1.46K | 0.12% | 175 |
|
|
2020
Q3 | $158K | Buy |
+2,507
| New | +$158K | 0.16% | 137 |
|